The Role of Consolidative Radiotherapy after a Complete Response to Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma in the Rituximab Era: Results from a Systematic Review with a Meta-Analysis

Publisher： Karger

E-ISSN： 1421-9662|134|2|111-118

ISSN： 0001-5792

Source： Acta Haematologica, Vol.134, Iss.2, 2015-04, pp. : 111-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Additional Support for Consolidative Radiotherapy for Diffuse Large B Cell Lymphoma in the Modern Rituximab Era

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 109-110

Karger

Access to resources Recommend Favorite

Prognostic value of complete remission status at end‐of‐treatment FDG‐PET in R‐CHOP‐treated diffuse large B‐cell lymphoma: systematic review and meta‐analysis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 185-191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radiation for diffuse large B‐cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1032-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of radiation therapy in primary mediastinal large B‐cell lymphoma in rituximab era: A US population‐based analysis

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1052-1054

John Wiley & Sons Inc

Access to resources Recommend Favorite

High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B‐cell lymphoma in first relapse: results of the R‐NIMP GOELAMS study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 240-249

John Wiley & Sons Inc

Access to resources Recommend Favorite